BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009; 15(18): 2190-2203 [PMID: 19437558 DOI: 10.3748/wjg.15.2190] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 54] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Zanelatto ADCO, Lacerda GDS, Accardo CDM, Rosário NFD, Silva AAD, Motta G, Tersariol ILDS, Xavier AR. Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection. Microorganisms 2022;10:1769. [DOI: 10.3390/microorganisms10091769] [Reference Citation Analysis]
2 Marri UK, Madhusudhan KS. Dual-Energy Computed Tomography in Diffuse Liver Diseases. Journal of Gastrointestinal and Abdominal Radiology. [DOI: 10.1055/s-0042-1742432] [Reference Citation Analysis]
3 Kaur N, Goyal G, Garg R, Tapasvi C, Chawla S, Kaur R. Potential role of noninvasive biomarkers during liver fibrosis. World J Hepatol 2021; 13(12): 1919-1935 [DOI: 10.4254/wjh.v13.i12.1919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dong B, Huang S, Chang J, Chen X, Yan J. Comparison of Sound Touch Elastography, Sound Touch Quantify, and 4 Serum Fibrosis Indexes for the Diagnosis of Liver Fibrosis in Patients With Chronic Hepatitis B. Ultrasound Q 2021;37:123-8. [PMID: 34057912 DOI: 10.1097/RUQ.0000000000000485] [Reference Citation Analysis]
5 Cervo A, Shengir M, Patel K, Sebastiani G. NASH in HIV. Curr HIV/AIDS Rep 2020;17:601-14. [PMID: 32984925 DOI: 10.1007/s11904-020-00531-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Marri UK, Das P, Shalimar, Kalaivani M, Srivastava DN, Madhusudhan KS. Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings. Radiology 2021;298:600-8. [PMID: 33399510 DOI: 10.1148/radiol.2021202232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
7 Rioux JA, Hewlett M, Davis C, Bowen CV, Brewer K, Clarke SE, Beyea SD. Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing. NMR Biomed 2021;34:e4241. [PMID: 31898379 DOI: 10.1002/nbm.4241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Winters AC, Mittal R, Schiano TD. A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post-liver transplant patient. Clin Transplant. 2019;33:e13700. [PMID: 31441967 DOI: 10.1111/ctr.13700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Srivastava A, Jong S, Gola A, Gailer R, Morgan S, Sennett K, Tanwar S, Pizzo E, O'Beirne J, Tsochatzis E, Parkes J, Rosenberg W. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease. BMC Gastroenterol 2019;19:122. [PMID: 31296161 DOI: 10.1186/s12876-019-1039-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
10 Wang TZ, Lin DD, Jin BX, Sun XY, Li N. Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging. Exp Ther Med. 2019;17:1919-1929. [PMID: 30783469 DOI: 10.3892/etm.2018.7117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sobhy A, Fakhry M M, A Azeem H, Ashmawy AM, Omar Khalifa H. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus. J Investig Med 2019;67:681-5. [PMID: 30385593 DOI: 10.1136/jim-2018-000840] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
12 Schachter JL, Patel M, Horton SR, Mike Devane A, Ewing A, Abrams GA. FibroSURE and elastography poorly predict the severity of liver fibrosis in Fontan-associated liver disease. Congenit Heart Dis 2018;13:764-70. [PMID: 30101472 DOI: 10.1111/chd.12650] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
13 Mebus S, Nagdyman N, Kügel J, Zachoval R, Braun SL, Haverkämper G, Opgen-Rhein B, Berger F, Horster S, Schoetzau J, Salvador CP, Bauer U, Hess J, Ewert P, Kaemmerer H. Non-invasive assessment of liver changes in Eisenmenger patients. Int J Cardiol 2017;249:140-4. [PMID: 29121718 DOI: 10.1016/j.ijcard.2017.07.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Omran D, Zayed RA, Nabeel MM, Mobarak L, Zakaria Z, Farid A, Hassany M, Saif S, Mostafa M, Saad OK, Yosry A. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients. Viral Immunol 2018;31:315-20. [PMID: 29630460 DOI: 10.1089/vim.2017.0134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Liu J, Ren W, Ai H, Dun G, Ji Y, Zhang Y, Wan Q, Lin S. Acoustic Structure Quantification Versus Point Shear Wave Speed Measurement for the Assessment of Liver Fibrosis in Viral Hepatitis B. Ultrasound Med Biol 2018;44:1177-86. [PMID: 29609809 DOI: 10.1016/j.ultrasmedbio.2018.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
16 Arslan FD, Karakoyun I, Tatar B, Pala EE, Yıldırım M, Ulasoglu C, Duman C, Akar H, Kose S, Isbilen Basok B. SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.63310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Bhat M, Tazari M, Sebastiani G. Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis. PLoS One. 2017;12:e0185192. [PMID: 28953939 DOI: 10.1371/journal.pone.0185192] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
18 Bhat M, Rollet-Kurhajec KC, Bhat A, Farag A, Deschenes M, Wong P, Ghali P, Sebastiani G. Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients. Can J Gastroenterol Hepatol 2017;2017:4381864. [PMID: 28409147 DOI: 10.1155/2017/4381864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Lin CL, Kao JH. New perspectives of biomarkers for the management of chronic hepatitis B. Clin Mol Hepatol. 2016;22:423-431. [PMID: 28081591 DOI: 10.3350/cmh.2016.0069] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
20 Zhuang Y, Ding H, Zhang Y, Sun H, Xu C, Wang W. Two-dimensional Shear-Wave Elastography Performance in the Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis B: Comparison with Serum Fibrosis Indexes. Radiology. 2017;283:873-882. [PMID: 27982760 DOI: 10.1148/radiol.2016160131] [Cited by in Crossref: 58] [Cited by in F6Publishing: 71] [Article Influence: 9.7] [Reference Citation Analysis]
21 Eminler AT, Ayyildiz T, Irak K, Kiyici M, Gurel S, Dolar E, Gulten M, Nak SG. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients. Eur J Gastroenterol Hepatol. 2015;27:1361-1366. [PMID: 26352130 DOI: 10.1097/meg.0000000000000468] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
22 Lin CL, Liu CH, Wang CC, Liang CC, Su TH, Liu CJ, Kao JH. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B. J Clin Gastroenterol. 2015;49:705-713. [PMID: 25319739 DOI: 10.1097/mcg.0000000000000250] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
23 Orasan OH, Iancu M, Sava M, Saplontai-Pop A, Cozma A, Sarlea ST, Lungoci C, Ungureanu MI, Negrean V, Sampelean D, Dumitrascu DL. Non-invasive assessment of liver fibrosis in chronic viral hepatitis. Eur J Clin Invest 2015;45:1243-51. [PMID: 26426402 DOI: 10.1111/eci.12543] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
24 Bhat M, Ghali P, Rollet-Kurhajec KC, Bhat A, Wong P, Deschenes M, Sebastiani G. Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients. Liver Transpl. 2015;21:1383-1394. [PMID: 26194602 DOI: 10.1002/lt.24217] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
25 Chindamo MC, Nunes-pannain VL, Araújo-neto JM, Moraes-coelho HS, Luiz RR, Villela-nogueira CA, Perez RM. Intermediate fibrosis staging in hepatitis C: a problem not overcome by optimal samples or pathologists’ expertise. Annals of Hepatology 2015;14:652-7. [DOI: 10.1016/s1665-2681(19)30759-8] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
26 Sebastiani G, Alshaalan R, Wong P, Rubino M, Salman A, Metrakos P, Deschenes M, Ghali P. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis. PLoS One. 2015;10:e0128774. [PMID: 26083565 DOI: 10.1371/journal.pone.0128774] [Cited by in Crossref: 35] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
27 Sun B, Li YG, Lan YH. Fibroscan for diagnosis and treatment of chronic liver disease. Shijie Huaren Xiaohua Zazhi 2015; 23(9): 1433-1439 [DOI: 10.11569/wcjd.v23.i9.1433] [Reference Citation Analysis]
28 Stefanescu H, Radu C, Procopet B, Lupsor-Platon M, Habic A, Tantau M, Grigorescu M. Non-invasive ménage à trois for the prediction of high-risk varices: stepwise algorithm using lok score, liver and spleen stiffness. Liver Int. 2015;35:317-325. [PMID: 25228102 DOI: 10.1111/liv.12687] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
29 Silva Junior RG, Schmillevitch J, Nascimento Mde F, Miranda ML, Brant PE, Schulz PO, Vieira A, Szutan LA. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C. Scand J Gastroenterol. 2014;49:986-992. [PMID: 24742130 DOI: 10.3109/00365521.2014.909528] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
30 Fallatah HI. Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 2014;2014:1-15. [DOI: 10.1155/2014/357287] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
31 Feuth T, Arends JE, Lieveld FI, Mundt MW, Hoepelman AI, Siersema PD, van Erpecum KJ. Impact of transient elastography on clinical decision-making in patients with chronic viral hepatitis. Scand J Gastroenterol 2013;48:1074-81. [PMID: 23886398 DOI: 10.3109/00365521.2013.819441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
32 Zarski JP, Sturm N, Guechot J, Zafrani ES, Vaubourdolle M, Thoret S, Margier J, David-Tchouda S, Bosson JL. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C. PLoS One 2013;8:e59088. [PMID: 23555619 DOI: 10.1371/journal.pone.0059088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
33 Zarski JP, Sturm N, Guechot J, Zafrani ES, Vaubourdolle M, Thoret S, Margier J, David-Tchouda S, Bosson JL. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C. PLoS One. 2013;8:e59088. [PMID: 23555619 DOI: 10.1371/journal.pone.0059088.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Attallah AM, El-Far M, Omran MM, Farid K, Albannan MS, El-Dosoky I. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients. J Clin Lab Anal 2013;27:121-9. [PMID: 23460258 DOI: 10.1002/jcla.21572] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
35 Tsang JPK, Poon WL, Luk HM, Fung CW, Ching CK, Mak CM, Lam CW, Siu TS, Tam S, Wong VC. Arginase Deficiency With New Phenotype and a Novel Mutation: Contemporary Summary. Pediatric Neurology 2012;47:263-9. [DOI: 10.1016/j.pediatrneurol.2012.06.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
36 Gao X, Shi D, Chen Y, Cui J, Wang Y, Jiang C, Wu J. The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation. Arch Pharm Res 2012;35:1479-93. [DOI: 10.1007/s12272-012-0819-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
37 El-Shabrawi MH, Zein El Abedin MY, Omar N, Kamal NM, Elmakarem SA, Khattab S, El-Sayed HM, El-Hennawy A, Ali AS. Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major. Arab J Gastroenterol. 2012;13:45-48. [PMID: 22980590 DOI: 10.1016/j.ajg.2012.06.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
38 Fouad SA, Esmat S, Omran D, Rashid L, Kobaisi MH. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection. World J Gastroenterol 2012; 18(23): 2988-2994 [PMID: 22736923 DOI: 10.3748/wjg.v18.i23.2988] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
39 Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E, Tenlik I, Kalkan IH, Beyazit Y, Yuksel O. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clin Res Hepatol Gastroenterol. 2013;37:41-46. [PMID: 22572524 DOI: 10.1016/j.clinre.2012.03.035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
40 Sebastiani G, Alberti A. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? J Viral Hepat. 2012;19 Suppl 1:18-32. [PMID: 22233410 DOI: 10.1111/j.1365-2893.2011.01518.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
41 Bruha R, Dvorak K, Petrtyl J. Alcoholic liver disease. World J Hepatol 2012; 4(3): 81-90 [PMID: 22489260 DOI: 10.4254/wjh.v4.i3.81] [Cited by in Crossref: 116] [Cited by in F6Publishing: 99] [Article Influence: 11.6] [Reference Citation Analysis]
42 O'Connor M, Mangus RS, Tector AJ, Fridell JA, Vianna RM. Utility of liver function tests including aminotransferase-to-platelet ratio index in monitoring liver dysfunction in short-gut infants of varying ages and intestinal lengths. J Pediatr Surg 2011;46:1057-63. [PMID: 21683198 DOI: 10.1016/j.jpedsurg.2011.03.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
43 Helaly GF, Hussein NG, Refai W, Ibrahim M. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance. Translational Research 2011;158:155-62. [DOI: 10.1016/j.trsl.2011.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
44 Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, Boisson RC, Bosson JL, Guyader D, Renversez JC, Bronowicki JP, Gelineau MC, Tran A, Trocme C, De Ledinghen V, Lasnier E, Poujol-Robert A, Ziegler F, Bourliere M, Voitot H, Larrey D, Rosenthal-Allieri MA, Fouchard Hubert I, Bailly F, Vaubourdolle M;  ANRS HCEP 23 Fibrostar Group. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol. 2012;56:55-62. [PMID: 21781944 DOI: 10.1016/j.jhep.2011.05.024] [Cited by in Crossref: 142] [Cited by in F6Publishing: 131] [Article Influence: 12.9] [Reference Citation Analysis]
45 Lee HS, Kim JK, Cheong JY, Han EJ, An SY, Song JH, Jung YJ, Jeon SC, Jung MW, Jang EJ. Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis. Korean J Hepatol. 2010;16:369-375. [PMID: 21415580 DOI: 10.3350/kjhep.2010.16.4.369] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
46 Omran MM, Farid K, Emran TM, Attallah AA. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab J Gastroenterol. 2011;12:74-79. [PMID: 21684477 DOI: 10.1016/j.ajg.2011.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
47 Barbosa JA, Rodrigues AB, Mota CC, Barbosa MM, Simões e Silva AC. Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods. Vasc Health Risk Manag 2011;7:287-95. [PMID: 21633726 DOI: 10.2147/VHRM.S17801] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
48 El-attar MM, Rashed HG, Sewify EM, Hassan HE. A suggested algorithm for using serum biomarkers for the diagnosis of liver fibrosis in chronic hepatitis C infection. Arab Journal of Gastroenterology 2010;11:206-11. [DOI: 10.1016/j.ajg.2010.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
49 Mangus RS, O'Connor MG, Tector AJ, Lim JD, Vianna RM. Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut. J Pediatr Surg 2010;45:1266-73. [PMID: 20620330 DOI: 10.1016/j.jpedsurg.2010.02.098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
50 Sebastiani G, Gkouvatsos K, Plebani M. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. Clin Chem Lab Med. 2011;49:13-32. [PMID: 20961196 DOI: 10.1515/cclm.2011.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
51 Zhan YT, An W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16(37): 4652-4660 [PMID: 20872965 DOI: 10.3748/wjg.v16.i37.4652] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 68] [Article Influence: 5.6] [Reference Citation Analysis]
52 Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54:64-71. [PMID: 20932598 DOI: 10.1016/j.jhep.2010.06.022] [Cited by in Crossref: 158] [Cited by in F6Publishing: 152] [Article Influence: 13.2] [Reference Citation Analysis]
53 Patel K. Noninvasive tools to assess liver disease. Curr Opin Gastroenterol. 2010;26:227-233. [PMID: 20179592 DOI: 10.1097/MOG.0b013e3283383c68] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
54 Miranda-Mendez A, Lugo-Baruqui A, Armendariz-Borunda J. Molecular basis and current treatment for alcoholic liver disease. Int J Environ Res Public Health. 2010;7:1872-1888. [PMID: 20622998 DOI: 10.3390/ijerph7051872] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]